Terms: = Sarcomas AND STAT5B, STAT5, 6777, ENSG00000173757, P51692
35 results:
1. Anticancer effect of crizotinib on osteosarcoma cells by targeting c-Met signaling pathway.
Jia T; Cai M; Wang Z; Chen T
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):174-178. PubMed ID: 37571883
[TBL] [Abstract] [Full Text] [Related]
2. PAK1 overexpression promotes myxofibrosarcoma angiogenesis through stat5b-mediated
Li CF; Chan TC; Fang FM; Yu SC; Huang HY
Int J Biol Sci; 2023; 19(12):3920-3936. PubMed ID: 37564209
[TBL] [Abstract] [Full Text] [Related]
3. FAT10 stimulates the development of osteosarcoma by regulating the JAK/STAT signaling pathway.
Shi F; Li L; Cheng Y
J BUON; 2021; 26(5):2090-2096. PubMed ID: 34761621
[TBL] [Abstract] [Full Text] [Related]
4. Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2
Chu Y; Nayyar G; Jiang S; Rosenblum JM; Soon-Shiong P; Safrit JT; Lee DA; Cairo MS
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34244307
[TBL] [Abstract] [Full Text] [Related]
5. Suppressing stat5 signaling affects osteosarcoma growth and stemness.
Subramaniam D; Angulo P; Ponnurangam S; Dandawate P; Ramamoorthy P; Srinivasan P; Iwakuma T; Weir SJ; Chastain K; Anant S
Cell Death Dis; 2020 Feb; 11(2):149. PubMed ID: 32094348
[TBL] [Abstract] [Full Text] [Related]
6. Decreased expression of stat5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract] [Full Text] [Related]
7. GH directly stimulates UCP3 expression.
Hayashi M; Futawaka K; Matsushita M; Koyama R; Fun Y; Fukuda Y; Nushida A; Nezu S; Tagami T; Moriyama K
Growth Horm IGF Res; 2018 Jun; 40():44-54. PubMed ID: 29398371
[TBL] [Abstract] [Full Text] [Related]
8. Viral microRNAs Target a Gene Network, Inhibit STAT Activation, and Suppress Interferon Responses.
Ramalingam D; Ziegelbauer JM
Sci Rep; 2017 Jan; 7():40813. PubMed ID: 28102325
[TBL] [Abstract] [Full Text] [Related]
9. Growth hormone regulates the expression of UCP2 in myocytes.
Futawaka K; Tagami T; Fukuda Y; Koyama R; Nushida A; Nezu S; Imamoto M; Kasahara M; Moriyama K
Growth Horm IGF Res; 2016 Aug; 29():57-62. PubMed ID: 27150070
[TBL] [Abstract] [Full Text] [Related]
10. Emerging EPO and EPO receptor regulators and signal transducers.
Kuhrt D; Wojchowski DM
Blood; 2015 Jun; 125(23):3536-41. PubMed ID: 25887776
[TBL] [Abstract] [Full Text] [Related]
11. High-throughput RNA sequencing-based virome analysis of 50 lymphoma cell lines from the Cancer Cell Line Encyclopedia project.
Cao S; Strong MJ; Wang X; Moss WN; Concha M; Lin Z; O'Grady T; Baddoo M; Fewell C; Renne R; Flemington EK
J Virol; 2015 Jan; 89(1):713-29. PubMed ID: 25355872
[TBL] [Abstract] [Full Text] [Related]
12. Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells.
Sandoval-Usme MC; Umaña-Pérez A; Guerra B; Hernández-Perera O; García-Castellano JM; Fernández-Pérez L; Sánchez-Gómez M
PLoS One; 2014; 9(1):e87769. PubMed ID: 24489959
[TBL] [Abstract] [Full Text] [Related]
13. Opposing regulation of PROX1 by interleukin-3 receptor and NOTCH directs differential host cell fate reprogramming by Kaposi sarcoma herpes virus.
Yoo J; Lee HN; Choi I; Choi D; Chung HK; Kim KE; Lee S; Aguilar B; Kang J; Park E; Lee YS; Maeng YS; Kim NY; Koh CJ; Hong YK
PLoS Pathog; 2012; 8(6):e1002770. PubMed ID: 22719258
[TBL] [Abstract] [Full Text] [Related]
14. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.
Chen YC; Chang CN; Hsu HC; Chiou SJ; Lee LT; Hseu TH
Life Sci; 2009 Jun; 84(25-26):915-22. PubMed ID: 19393247
[TBL] [Abstract] [Full Text] [Related]
15. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
Riccioni R; Diverio D; Riti V; Buffolino S; Mariani G; Boe A; Cedrone M; Ottone T; Foà R; Testa U
Br J Haematol; 2009 Feb; 144(3):376-87. PubMed ID: 19036083
[TBL] [Abstract] [Full Text] [Related]
16. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium.
Maruyama T; Yoshimura Y
Endocr J; 2008 Oct; 55(5):795-810. PubMed ID: 18580040
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
[TBL] [Abstract] [Full Text] [Related]
18. Activation of SRC kinase and phosphorylation of signal transducer and activator of transcription-5 are required for decidual transformation of human endometrial stromal cells.
Nagashima T; Maruyama T; Uchida H; Kajitani T; Arase T; Ono M; Oda H; Kagami M; Masuda H; Nishikawa S; Asada H; Yoshimura Y
Endocrinology; 2008 Mar; 149(3):1227-34. PubMed ID: 18063684
[TBL] [Abstract] [Full Text] [Related]
19. Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on stat5 and p53.
Chipoy C; Brounais B; Trichet V; Battaglia S; Berreur M; Oliver L; Juin P; Rédini F; Heymann D; Blanchard F
Oncogene; 2007 Oct; 26(46):6653-64. PubMed ID: 17471233
[TBL] [Abstract] [Full Text] [Related]
20. The Src signaling pathway: a potential target in melanoma and other malignancies.
Homsi J; Cubitt C; Daud A
Expert Opin Ther Targets; 2007 Jan; 11(1):91-100. PubMed ID: 17150037
[TBL] [Abstract] [Full Text] [Related]
[Next]
